ACM
PRAH

Advisors Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Advisors Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,847
Closed -$1.36M – 383
2020
Q4 		$1.36M Buy
10,847
+2,232
+26% +$250K 0.05% 191
2020
Q3 		$874K Buy
8,615
+587
+7% +$59.8K 0.04% 192
2020
Q2 		$781K Buy
8,028
+472
+6% +$43.9K 0.04% 188
2020
Q1 		$627K Buy
7,556
+700
+10% +$68.3K 0.04% 191
2019
Q4 		$762K Buy
6,856
+1,020
+17% +$105K 0.04% 224
2019
Q3 		$579K Buy
5,836
+453
+8% +$45K 0.03% 215
2019
Q2 		$534K Buy
5,383
+1,643
+44% +$157K 0.03% 216
2019
Q1 		$415K Sell
3,740
-557
-13% -$58.2K 0.03% 218
2018
Q4 		$395K Buy
+4,297
New +$435K 0.03% 227

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Advisors Capital Management's PRAH Position: Q1 2021 in Review

Advisors Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 10,847 shares — an estimated $1.36M sold.

Advisors Capital Management first reported a position in PRAH in Q4 2018 and held it in 9 quarters. The position peaked at $1.36M in Q4 2020. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

  • Advisors Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Advisors Capital Management sold 10,847 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $1.36M.
  • Advisors Capital Management first reported a position in PRA Health Sciences, Inc. in Q4 2018 and held it in 9 quarters.
  • Advisors Capital Management's PRA Health Sciences, Inc. position peaked at $1.36M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on Advisors Capital Management's 13F filing for Q1 2021, filed 12 May 2021.